Gene · 1031
Papers2,553
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,553
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Distinct transcriptomic signatures define febrile malaria depending on initial infective states, asymptomatic or uninfected. | BMC Infect Dis | 2024 | 38287287 | PubTator, text mining | PubMed |
| MAFF confers vulnerability to cisplatin-based and ionizing radiation treatments by modulating ferroptosis and cell cycle progression in lung adenocarcinoma. | Drug Resist Updat | 2024 | 38266355 | PubTator, text mining | PubMed |
| DNA Sequencing of CD138 Cell Population Reveals TP53 and RAS-MAPK Mutations in Multiple Myeloma at Diagnosis. | Cancers (Basel) | 2024 | 38254847 | PubTator, text mining | PubMed |
| Li-Fraumeni syndrome presenting with de novo TP53 mutation, severe phenotype and advanced paternal age: a case report. | Hered Cancer Clin Pract | 2024 | 38238849 | PubTator, text mining | PubMed |
| Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience. | Blood Cancer J | 2024 | 38199987 | PubTator, text mining | PubMed |
| N6-methyladenosine methylation analysis of long noncoding RNAs and mRNAs in 5-FU-resistant colon cancer cells. | Epigenetics | 2024 | 38145548 | PubTator, text mining | PubMed |
| Tumor diagnosis using carbon-based quantum dots: Detection based on the hallmarks of cancer. | Bioact Mater | 2024 | 38034499 | PubTator, text mining | PubMed |
| Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis. | Brain | 2024 | 37930324 | PubTator, text mining | PubMed |
| Cuprotosis clusters predict prognosis and immunotherapy response in low-grade glioma. | Apoptosis | 2024 | 37713112 | PubTator, text mining | PubMed |
| The emerging roles of lysine-specific demethylase 4A in cancer: Implications in tumorigenesis and therapeutic opportunities. | Genes Dis | 2024 | 37692513 | PubTator, text mining | PubMed |
| From Genes to Therapy: Pituitary Adenomas in the Era of Precision Medicine. | Biomedicines | 2023 | 38275385 | PubTator, text mining | PubMed |
| Characterization of prevalent tyrosine kinase inhibitors and their challenges in glioblastoma treatment. | Front Chem | 2023 | 38264122 | PubTator, text mining | PubMed |
| Gene signatures associated with prognosis and chemotherapy resistance in glioblastoma treated with temozolomide. | Front Genet | 2023 | 38259614 | PubTator, text mining | PubMed |
| Embelin: A multifaceted anticancer agent with translational potential in targeting tumor progression and metastasis. | EXCLI J | 2023 | 38234968 | PubTator, text mining | PubMed |
| Establishment and Characterization of Cell Lines from Canine Metastatic Osteosarcoma. | Cells | 2023 | 38201229 | PubTator, text mining | PubMed |
| Comprehensive analysis of senescence-related genes and immune infiltration in intervertebral disc degeneration: a meta-data approach utilizing bulk and single-cell RNA sequencing data. | Front Mol Biosci | 2023 | 38187091 | PubTator, text mining | PubMed |
| An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline SDHB pathogenic variant in the absence of paraganglioma or pheochromocytoma. | Front Endocrinol (Lausanne) | 2023 | 38152133 | PubTator, text mining | PubMed |
| CEA cell adhesion molecule 5 enriches functional human hematopoietic stem cells capable of long-term multi-lineage engraftment. | iScience | 2023 | 38144459 | PubTator, text mining | PubMed |
| GCM2 p.Tyr394Ser variant in Ashkenazi Israeli patients with suspected familial isolated hyperparathyroidism. | Front Endocrinol (Lausanne) | 2023 | 38130397 | PubTator, text mining | PubMed |
| MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting. | Nat Commun | 2023 | 38102140 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1031/papers?page=4